A recent Washington Post article shared the experiences of patients who wanted to “go flat” rather than undergoing breast mound reconstruction after mastectomy. The article examined how sentiment toward flat closure has changed over time. Despite growing awareness, many patients report their doctors never spoke to them about the option to go flat or even […]
On January 19, Susan G. Komen announced it would accept more than 70 kinds of donated cryptocurrency.
The omnibus COVID-19 economic relief and appropriations package included many issues that Susan G. Komen advocates have long been pursuing.
Major breast cancer news was announced at the 2020 European Society of Medical Oncology.
Telemedicine, or meeting with your doctor over the phone or computer, has been more widely used recently than in the past due to the COVID-19 pandemic. That’s in large part due to Congress lifting restrictions on its use. The New York Times recently published an article that looked at whether or not telemedicine is here […]
New federal guidance recommends that breast cancer clinical trials be open to men – who are being diagnosed with and dying from the disease – but have largely been excluded from clinical trials. An estimated 2,620 men will be diagnosed with breast cancer in 2020 and 502 will die from it in the US. Although […]
The census is now open for everyone to complete. It is important that every household in the U.S. participates because the information collected informs so many important decisions about the next 10 years. Here are a few things impacted by census data: the census informs the number of representatives each state has in Congress, how […]
New data shows Latinos and Blacks are more likely to contract COVID-19 and die from it, but the data is incomplete and only tells part of the picture.
Susan G. Komen’s Susan Brown addresses recent news that breast cancer deaths will increase because of COVID-19.
Patients and doctors should discuss scheduled surgeries in light of COVID-19 developments.
Research findings from the AURORA study announced at the 2019 San Antonio Breast Cancer Symposium provide more information about how breast cancer evolves, from the site of its origin to the metastatic site.
The 2019 San Antonio Breast Cancer Symposium (SABCS) kicked off with the presentation of two clinical trials that showed groundbreaking findings, adding to the treatment options for people with HER2-positive metastatic breast cancer.